Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS-CoV-2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus.


Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 13 05 2022
received: 04 03 2022
accepted: 15 05 2022
pubmed: 19 5 2022
medline: 30 9 2022
entrez: 18 5 2022
Statut: ppublish

Résumé

Wildlife animals may be susceptible to multiple infectious agents of public health or veterinary relevance, thereby potentially forming a reservoir that bears the constant risk of re-introduction into the human or livestock population. Here, we serologically investigated 493 wild ruminant samples collected in the 2021/2022 hunting season in Germany for the presence of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and four viruses pathogenic to domestic ruminants, namely, the orthobunyavirus Schmallenberg virus (SBV), the reovirus bluetongue virus (BTV) and ruminant pestiviruses like bovine viral diarrhoea virus or border disease virus. The animal species comprised fallow deer, red deer, roe deer, mouflon and wisent. For coronavirus serology, additional 307 fallow, roe and red deer samples collected between 2017 and 2020 at three military training areas were included. While antibodies against SBV could be detected in about 13.6% of the samples collected in 2021/2022, only one fallow deer of unknown age tested positive for anti-BTV antibodies, and all samples reacted negative for antibodies against ruminant pestiviruses. In an ELISA based on the receptor-binding domain (RBD) of SARS-CoV-2, 25 out of 493 (5.1%) samples collected in autumn and winter 2021/2022 scored positive. This sero-reactivity could not be confirmed by the highly specific virus neutralisation test, occurred also in 2017, 2018 and 2019, that is, prior to the human SARS-CoV-2 pandemic, and was likewise observed against the RBD of the related SARS-CoV-1. Therefore, the SARS-CoV-2 sero-reactivity was most likely induced by another hitherto unknown deer virus belonging to the subgenus Sarbecovirus of betacoronaviruses.

Identifiants

pubmed: 35585653
doi: 10.1111/tbed.14600
pmc: PMC9348064
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3289-e3296

Subventions

Organisme : German Federal Ministry of Food and Agriculture (BMEL)
Organisme : BMEL through the Federal Office for Agriculture and Food (BLE)
Organisme : European Union Horizon 2020 project 'European Virus Archive goes global' (EVAg)
Organisme : Animal Disease Funds (Tierseuchenkassen) of the German federal states Lower Saxony, Thuringia, Hesse, Rhineland-Palatinate, North Rhine-Westphalia and the Ministry of Energy, Agriculture, the Environment, Nature and Digitalization of the German federal state Schleswig-Holstein

Informations de copyright

© 2022 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH.

Références

Transbound Emerg Dis. 2020 May;67(3):1401-1405
pubmed: 31883429
Front Vet Sci. 2020 Feb 21;7:3
pubmed: 32154271
PeerJ. 2020 Feb 18;8:e8114
pubmed: 32110477
Nature. 2022 Feb;602(7897):481-486
pubmed: 34942632
Transbound Emerg Dis. 2022 Sep;69(5):e3289-e3296
pubmed: 35585653
Vet Rec. 2018 Dec 8;183(22):688-689
pubmed: 30523184
Emerg Infect Dis. 2012 Mar;18(3):469-72
pubmed: 22376991
Lancet Microbe. 2020 Sep;1(5):e218-e225
pubmed: 32838346
Pathogens. 2017 Oct 18;6(4):
pubmed: 29057796
Emerg Microbes Infect. 2021 Dec;10(1):2199-2201
pubmed: 34749583
Front Microbiol. 2016 Jan 07;6:1415
pubmed: 26779126
Prev Vet Med. 2011 Nov 1;102(2):107-11
pubmed: 21570141
Anim Health Res Rev. 2018 Dec;19(2):113-124
pubmed: 30683171
Transbound Emerg Dis. 2021 Jul;68(4):1779-1785
pubmed: 33191578
Emerg Infect Dis. 2020 Dec;26(12):2979-2981
pubmed: 33034284
Vet Res. 1998 May-Aug;29(3-4):327-40
pubmed: 9689745
Emerg Microbes Infect. 2022 Dec;11(1):95-112
pubmed: 34842046
J Wildl Dis. 1995 Apr;31(2):247-50
pubmed: 8583646
Transbound Emerg Dis. 2017 Oct;64(5):1411-1423
pubmed: 27291825
Emerg Infect Dis. 2022 Sep;28(9):1916-1918
pubmed: 35914515
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Transbound Emerg Dis. 2016 Oct;63(5):e339-46
pubmed: 25482024
J Virol. 2008 Dec;82(24):12422-31
pubmed: 18842722
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):
pubmed: 34732584
J Virol. 2021 Mar 10;:
pubmed: 33692203
Transbound Emerg Dis. 2022 Sep;69(5):e1815-e1824
pubmed: 35304824
Transbound Emerg Dis. 2020 Jul;67(4):1708-1715
pubmed: 31991522
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
Virus Res. 2014 Mar;182:50-8
pubmed: 24394295
Emerg Infect Dis. 2012 Dec;18(12):2006-8
pubmed: 23171763
Transbound Emerg Dis. 2020 Nov;67(6):2290-2295
pubmed: 32320536
Vet Res. 2015 Sep 23;46:99
pubmed: 26394618
Vet Res. 2010 Mar-Apr;41(2):20
pubmed: 19922743
Vet Res. 2008 Sep-Oct;39(5):39
pubmed: 18346451
J Wildl Dis. 2019 Jan;55(1):3-43
pubmed: 30284963
Rev Sci Tech. 2021 Jun;40(1):105-118
pubmed: 34140737
Vet Sci. 2021 Jan 18;8(1):
pubmed: 33477718
Emerg Microbes Infect. 2022 Dec;11(1):662-675
pubmed: 35105272
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Transbound Emerg Dis. 2017 Jun;64(3):998-1000
pubmed: 26617414
Viruses. 2019 Sep 27;11(10):
pubmed: 31569721
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35078920

Auteurs

Kerstin Wernike (K)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Luisa Fischer (L)

State Agency for Nature, Environment and Consumer Protection North Rhine-Westphalia, Wildlife Research Institute, Bonn, Germany.

Mark Holsteg (M)

Chamber of Agriculture for North Rhine-Westphalia, Bovine Health Service, Bad Sassendorf, Germany.

Andrea Aebischer (A)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Anja Petrov (A)

Central Institute of the Bundeswehr Medical Service Kiel, Kronshagen, Germany.

Katharina Marquart (K)

Central Institute of the Bundeswehr Medical Service Kiel, Kronshagen, Germany.

Ulrich Schotte (U)

Central Institute of the Bundeswehr Medical Service Kiel, Kronshagen, Germany.

Jacob Schön (J)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Donata Hoffmann (D)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Silke Hechinger (S)

Landesbetrieb Hessisches Landeslabor, Gießen, Germany.

Antonie Neubauer-Juric (A)

Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Julia Blicke (J)

Ministry of Climate Protection, Environment, Energy and Mobility, Mainz, Germany.

Thomas C Mettenleiter (TC)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Martin Beer (M)

Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH